Keros Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Keros Therapeutics, Inc. (KROS) had Operating Lease, Weighted Average Discount Rate, Percent of 10.30% as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-03-04
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.30%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.30%.
- 2024-09-30: Operating Lease, Weighted Average Discount Rate, Percent 10.30%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.30%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 10.30% 10-K · filed 2026-03-04 |
| 2024-12-31 | 10.30% 10-K · filed 2026-03-04 |
| 2024-09-30 | 10.30% 10-Q · filed 2024-11-06 |
| 2023-12-31 | 10.30% 10-K · filed 2025-02-26 |
| 2023-09-30 | 10.34% 10-Q · filed 2023-11-06 |
| 2023-06-30 | 10.34% 10-Q · filed 2023-08-07 |
| 2023-03-31 | 10.34% 10-Q · filed 2023-05-04 |
| 2022-12-31 | 10.00% 10-K · filed 2024-02-28 |
| 2021-12-31 | 7.27% 10-K · filed 2022-03-09 |
| 2021-09-30 | 7.27% 10-Q · filed 2021-11-04 |
| 2020-12-31 | 8.02% 10-K · filed 2022-03-09 |
| 2020-09-30 | 8.02% 10-Q · filed 2021-11-04 |
| 2019-12-31 | 8.02% 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |